...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: April 28 - 29 | Exclusive Digital Event-Triple Negative Breast Cancer

Nice find Koo. Here is a web link for this event.

https://tnbc-summit.com/about/virtual-event-information/

 

Share
New Message
Please login to post a reply